Vir Biotechnology, Inc.
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection unde…
Biotechnology
US, San Francisco [HQ]
Balance Sheet
7 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | 251.00 | 191.00 | 512.00 | 918.00 | 1,954.00 | 2,802.00 | 1,960.00 | |
|
Current
|
192.00 | 117.00 | 402.00 | 772.00 | 1,562.00 | 2,519.00 | 1,588.00 | |
| Cash And Equivalents | 187.00 | 47.00 | 109.00 | 436.00 | 347.00 | 848.00 | 254.00 | |
| Assets | 251.00 | 191.00 | 512.00 | 918.00 | 1,954.00 | 2,802.00 | 1,960.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | -773.00 | 770.00 | - - | |
| Inventory | - - | - - | - - | - - | 8.00 | - - | - - | |
| Short Term Investments | - - | 50.00 | 274.00 | 300.00 | 360.00 | 1,553.00 | 1,280.00 | |
| Other Current Assets | 4.00 | 8.00 | 13.00 | 27.00 | 73.00 | 104.00 | 40.00 | |
|
Non Current
|
59.00 | 73.00 | 109.00 | 146.00 | 391.00 | 283.00 | 371.00 | |
| Property, Plant, Equipment (Net) | 5.00 | 12.00 | 16.00 | 79.00 | 130.00 | 188.00 | 167.00 | |
|
Intangible Assets
|
35.00 | 36.00 | 35.00 | 33.00 | 33.00 | 32.00 | 22.00 | |
| Goodwill | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | |
| Long Term Investments | - - | - - | 24.00 | 12.00 | 201.00 | 23.00 | 111.00 | |
| Other Non Current Assets | 1.00 | 7.00 | 15.00 | 15.00 | -87.00 | -228.00 | 12.00 | |
| Liabilities | 320.00 | 370.00 | 88.00 | 201.00 | 522.00 | 724.00 | 369.00 | |
|
Current
|
12.00 | 39.00 | 59.00 | 99.00 | 341.00 | 511.00 | 175.00 | |
| Accounts Payable | 2.00 | 1.00 | - - | - - | - - | - - | - - | |
| Short Term Debt | - - | 14.00 | - - | 3.00 | 3.00 | 4.00 | 12.00 | |
| Deferred Revenue | - - | 8.00 | 6.00 | 6.00 | 98.00 | 15.00 | 64.00 | |
| Tax Payable | - - | - - | - - | - - | 6.00 | 15.00 | - - | |
| Other Current Liabilities | 7.00 | 10.00 | 46.00 | 83.00 | 232.00 | 484.00 | 91.00 | |
|
Non Current
|
308.00 | 330.00 | 28.00 | 102.00 | 181.00 | 213.00 | 194.00 | |
| Long Term Debt | 293.00 | 310.00 | - - | 66.00 | 133.00 | 123.00 | 111.00 | |
| Leasing Obligations | - - | - - | - - | 66.00 | 133.00 | 123.00 | 111.00 | |
| Deferred Non Current Tax Liabilities | 3.00 | 3.00 | 3.00 | 3.00 | 18.00 | 3.00 | 43.00 | |
| Other Non Current Liabilities | 10.00 | 10.00 | 12.00 | 29.00 | 25.00 | 32.00 | 38.00 | |
| Equity | -68.00 | -179.00 | 423.00 | 716.00 | 1,431.00 | 2,077.00 | 1,590.00 | |
| Stockholders' Equity | -68.00 | -179.00 | 423.00 | 716.00 | 1,431.00 | 2,077.00 | 1,590.00 | |
| Retained Earnings | -77.00 | -193.00 | -368.00 | -667.00 | -138.00 | 377.00 | -237.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | 512.00 | - - | - - | - - | - - | |
| Profit | -69.00 | -115.00 | -174.00 | -298.00 | 528.00 | 515.00 | -615.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 9.00 | 14.00 | 280.00 | 1,385.00 | 1,571.00 | 1,709.00 | 1,828.00 | |
| Loss Other Compr. Income | - - | - - | - - | -1.00 | -1.00 | -9.00 | - - |